首页> 外国专利> condensation products with antitumoraktivitet, erhallna by condensation of alpha aminoisopropylfenylketon, via karbonylgruppens c = o bonding.with substituted amines or hydrazines or with funktionssubstituerade

condensation products with antitumoraktivitet, erhallna by condensation of alpha aminoisopropylfenylketon, via karbonylgruppens c = o bonding.with substituted amines or hydrazines or with funktionssubstituerade

机译:缩合产物与抗肿瘤药,通过核糖基团c = o键与α氨基异丙基去甲酮缩合,与取代的胺或肼或官能团取代

摘要

Cpds. of formula Ph-C(=NR)-C(Me)2-NH2 (I) are new (where R is NHCSNH2, NHCOOC(Me)3, NHCH2COOEt, CH(Me)CH2CH2CH(Et)2 or CH(R')CONH2; R' is H, Me, i-Pr, CH2Ph, 3-indolyl, CH2CH2SMe or CH2OH). - (I) are antitumour agents, e.g. active against Lewis carcinoma at doses of 138-229 mg/kg, adenocarcinoma 755 at 30 mg/kg, sarcoma 37 at 30-83 mg/kg and Ehrlich carcinoma at 45-138 mg/kg (i.p., mouse). - (I) is prepd. by reacting cpd. of formula (II) with cpd. of formula RNH2 in stoichiometric amts. The reaction is carried out in methanol at 17-20 deg.C. Cpd. (II) may be prepd. by alkaline decomposition of a quaternised salt of isopropyl phenyl ketone N,N-dimethylhydrazone.
机译:Cpds。式Ph-C(= NR)-C(Me)2-NH2(I)的化合物是新的(其中R是NHCSNH2,NHCOOC(Me)3,NHCH2COOEt,CH(Me)CH2CH2CH(Et)2或CH(R' CONH 2; R'为H,Me,i-Pr,CH 2 Ph,3-吲哚基,CH 2 CH 2 SMe或CH 2 OH)。 -(I)是抗肿瘤药,例如分别以138-229 mg / kg的剂量抗Lewis癌,30 mg / kg的腺癌755、30-83 mg / kg的肉瘤37和45-138 mg / kg的Ehrlich癌(i.p.,小鼠)。 -(I)已准备好。通过反应cpd。用cpd表示式(II)。化学计量的式RNH2的化学式。该反应在甲醇中在17-20℃下进行。 CPD。 (II)可以准备。通过碱分解异丙基苯基酮N,N-二甲基hydr的季铵盐

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号